Calorie Restrictions, Low-Fat Diets May Reduce Depressive Symptoms
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
MONDAY, May 19, 2025 -- Among adults with elevated cardiometabolic risk, calorie restrictions and low-fat diets may reduce depressive symptoms, according to a review published online May 20 in the Annals of Internal Medicine.
Eman Abukmail, M.D., from the Institute for Evidence Based Healthcare at Bond University in Gold Coast, Australia, and colleagues examined the effects of dietary interventions on depression and anxiety in a systematic review of randomized controlled trials. Data were included from 25 randomized controlled trials.
The researchers found that for adults with elevated cardiometabolic risk, depressive symptoms might be improved by dietary advice on calorie restriction compared with no specific dietary advice (standardized mean difference, −0.23; low-certainty). Small effects on depressive symptoms may be seen with low-fat diets among adults with elevated cardiometabolic risk (standardized mean difference, −0.03). Limited evidence was seen for other diets, comparing diets with active comparisons, and on anxiety.
"In conclusion, calorie restrictions and low-fat diets might reduce depressive symptoms among adults with elevated cardiometabolic risk, but the differences were small, and confidence in the findings was low," the authors write. "Evidence on other diets, comparisons to active interventions, and other outcomes is limited."
Abstract/Full Text (subscription or payment may be required
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-05-20 12:00
Read more

- Risky Health Behaviors Tied to Poorer Mental Well-Being, General Health in Midlife
- Medicaid Unwinding Linked to Disruption of Chronic Medication Therapy in Youth
- Loneliness More Common Among Middle-Aged In U.S.
- Gluten-Free Diet for Celiac Disease Increases Arsenic Exposure in Children
- COVID Boosters Might Not Be Updated For Next Season, FDA Commissioner Says
- Muscle Quality Could Be Key To Successful Hip Replacement
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions